These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 12525881)
1. Detection of cancer cells in the peripheral blood of gastric cancer patients. Ikeguchi M; Ohro S; Maeda Y; Fukuda K; Yamaguchi K; Shirai H; Kondo A; Tsujitani S; Kaibara N Int J Mol Med; 2003 Feb; 11(2):217-21. PubMed ID: 12525881 [TBL] [Abstract][Full Text] [Related]
2. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345 [TBL] [Abstract][Full Text] [Related]
3. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. Shen C; Hu L; Xia L; Li Y Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519 [TBL] [Abstract][Full Text] [Related]
4. [CK20 mRNA expression in peripheral blood of patients with gastrointestinal carcinoma and its clinical significance]. Na GW; Li J; He KJ; Li HH; Zhao XN; Li XW; Mi HN Ai Zheng; 2004 Nov; 23(11):1350-3. PubMed ID: 15522189 [TBL] [Abstract][Full Text] [Related]
5. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782 [TBL] [Abstract][Full Text] [Related]
6. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease. Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172 [TBL] [Abstract][Full Text] [Related]
7. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR]. Zheng HY; Chen Q; Ye YB; Huang WW Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676 [TBL] [Abstract][Full Text] [Related]
8. [Significance of detecting disseminated tumor cells in peripheral blood of gastric and colorectal cancer patients]. Zhang XW; Fan P; Yang HY; Yang L; Chen GY Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):66-9. PubMed ID: 12678992 [TBL] [Abstract][Full Text] [Related]
9. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. Hampton R; Walker M; Marshall J; Juhl H Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218 [TBL] [Abstract][Full Text] [Related]
11. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355 [TBL] [Abstract][Full Text] [Related]
12. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers]. Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576 [TBL] [Abstract][Full Text] [Related]
14. Detection of circulating breast cancer cells with multiple-marker RT-PCR assay. Hu XC; Chow LW Anticancer Res; 2001; 21(1A):421-4. PubMed ID: 11299772 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients. Tamura N; Iinuma H; Takada T Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749 [TBL] [Abstract][Full Text] [Related]
16. [Detection of cytokeratin20 mRNA in peripheral blood from colonic cancer patients by fluorescence quantitative polymerase chain reaction]. Wang ZC; Wang C; Zeng QG Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):600-3. PubMed ID: 18210880 [TBL] [Abstract][Full Text] [Related]
17. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822 [TBL] [Abstract][Full Text] [Related]
18. Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. Aoki S; Takagi Y; Hayakawa M; Yamaguchi K; Futamura M; Kunieda K; Saji S J Exp Clin Cancer Res; 2002 Dec; 21(4):555-62. PubMed ID: 12636102 [TBL] [Abstract][Full Text] [Related]
19. CK20 gene expression: technical limits for the detection of circulating tumor cells. Champelovier P; Mongelard F; Seigneurin D Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150 [TBL] [Abstract][Full Text] [Related]
20. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. Ito H; Kanda T; Nishimaki T; Sato H; Nakagawa S; Hatakeyama K J Exp Clin Cancer Res; 2004 Sep; 23(3):455-64. PubMed ID: 15595636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]